The structure-bioavailability approach in antifungal agents

被引:12
作者
Grudzien, Monika [2 ]
Krol, Anna [2 ]
Paterek, Grazyna [2 ]
Stepien, Karolina [2 ]
Plucinski, Franciszek [1 ]
Mazurek, Alexander P. [1 ,2 ]
机构
[1] Natl Med Inst, PL-00725 Warsaw, Poland
[2] Warsaw Med Univ, Dept Drug Chem, PL-02097 Warsaw, Poland
关键词
Antifungal agent; BCS system; Bioavailability; STEROL; 14-ALPHA-DEMETHYLASE; RESISTANCE; CYP51; MECHANISMS; TARGETS; P450;
D O I
10.1016/j.ejmech.2008.10.028
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The thermodynamic and electrostatic properties of antifungal triazole and imidazole derivatives: itraconazole, fluconazole, miconazole and ketoconazole molecules were calculated. The main aim of our investigations was to identify molecular determinants that have an effect on bioavailability of studied compounds. This is solvation energy estimated by the Delta G values as well as electrostatic properties of the molecules. The influence of another substituents; was also considered. The presented values are discriminative and reflect very low solubility of ketoconazole in water in comparison with other molecules. The thermodynamic and electrostatic properties of molecules appeared to be good indicators of bioavailability of compounds studied here and they are likely to be used as screening parameters in Biopharmaceutical Classification System (BCS) development. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1978 / 1981
页数:4
相关论文
共 30 条
[1]   Rational design and synthesis of homochiral azole antifungal agents [J].
Botta, M ;
Corelli, F ;
Manetti, F ;
Mugnaini, C ;
Tafi, A .
PURE AND APPLIED CHEMISTRY, 2001, 73 (09) :1477-1485
[2]   Azole-based antimycotic agents inhibit mold on unseasoned pine [J].
Clausen, CA ;
Yang, VW .
INTERNATIONAL BIODETERIORATION & BIODEGRADATION, 2005, 55 (02) :99-102
[3]   Many facets of mammalian lanosterol 14α-demethylase from the evolutionarily conserved cytochrome P450 family CYP51 [J].
Debeljak, N ;
Fink, M ;
Rozman, D .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 409 (01) :159-171
[4]  
FDA, 2000, GUID IND WAIV IN VIV
[5]  
Frisch M.J., 1998, GAUSSIAN 98
[6]   Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance [J].
Ghannoum, MA ;
Rice, LB .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (04) :501-+
[7]   Modeling and interactions of Aspergillus fumigatus lanosterol 14-α demethylase 'A' with azole antifungals [J].
Gollapudy, R ;
Ajmani, S ;
Kulkarni, SA .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (11) :2937-2950
[8]  
Hehre W., 2000, Spartan Software
[9]   Interspecies comparison of pharmacokinetics of the novel triazole antifungal agent SYN-2869 and its derivatives [J].
Khan, JK ;
Montaseri, H ;
Poglod, M ;
Bu, HZ ;
Zuo, Z ;
Salama, SM ;
Daneshtalab, M ;
Micetich, RG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :910-915
[10]   Molecular aspects of azole antifungal action and resistance [J].
Lamb, D ;
Kelly, D ;
Kelly, S .
DRUG RESISTANCE UPDATES, 1999, 2 (06) :390-402